Sökning: id:"swepub:oai:DiVA.org:oru-56601" >
Use of proton pump ...
-
Lebwohl, BenjaminColl Phys & Surg, Dept Med, Celiac Dis Ctr, Columbia Univ, New York NY, USA; Dept Med, Clin Epidemiol Unit, Karolinska Univ Hosp, Stockholm, Sweden; Karolinska Inst, Stockholm, Sweden
(författare)
Use of proton pump inhibitors and subsequent risk of celiac disease
- Artikel/kapitelEngelska2014
Förlag, utgivningsår, omfång ...
-
Elsevier BV,2014
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:oru-56601
-
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-56601URI
-
https://doi.org/10.1016/j.dld.2013.08.128DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:128065993URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Background: The prevalence of celiac disease and the use of medications that inhibit acid secretion have both increased in recent decades. Aim: To explore the association between antisecretory medication exposure and subsequent development of celiac disease. Methods: In this population-based case control study, we identified patients with celiac disease diagnosed at all pathology departments in Sweden from July 2005 through February 2008. Patients were matched by age and gender with up to 5 controls. We identified prior prescriptions for proton pump inhibitors and histamine-2 receptor antagonists in all subjects. We used conditional logistic regression to measure the association between these prescriptions and the subsequent diagnosis of celiac disease. Results: Prior proton pump inhibitor prescription was strongly associated with celiac disease (OR 4.79; 95% CI 4.17-5.51). Patients prescribed both proton pump inhibitors and histamine-2 receptor antagonists had a higher risk of celiac disease (OR 5.96; 95% CI 3.58-9.91) than those prescribed proton pump inhibitors alone (OR 4.91; 95% CI 4.26-5.66) or histamine-2 receptor antagonists alone (OR 4.16; 95% CI 2.89-5.99). Conclusions: Exposure to antisecretory medications is associated with a subsequent diagnosis of celiac disease. The persistence of this association after excluding prescriptions in the year preceding the celiac disease diagnosis suggests a causal relationship. (C) 2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Spechler, Stuart J.Dept Internal Med, Div Gastroenterol, Department of Veterans Affairs North Texas Healthcare Syst, Dallas TX, USA; University of Texas Southwestern Med Ctr, Dallas TX, USA
(författare)
-
Wang, Timothy C.Coll Phys & Surg, Dept Med, Celiac Dis Ctr, Columbia Univ, New York NY, USA
(författare)
-
Green, Peter H. R.Coll Phys & Surg, Dept Med, Celiac Dis Ctr, Columbia Univ, New York NY, USA
(författare)
-
Ludvigsson, Jonas F.Karolinska Institutet,Region Örebro län,Dept Med, Clin Epidemiol Unit, Karolinska Univ Hosp, Stockholm, Sweden; Karolinska Inst, Stockholm, Sweden; Dept Pediat, Örebro Univ Hosp, Örebro, Sweden(Swepub:oru)jsln
(författare)
-
Coll Phys & Surg, Dept Med, Celiac Dis Ctr, Columbia Univ, New York NY, USA; Dept Med, Clin Epidemiol Unit, Karolinska Univ Hosp, Stockholm, Sweden; Karolinska Inst, Stockholm, SwedenDept Internal Med, Div Gastroenterol, Department of Veterans Affairs North Texas Healthcare Syst, Dallas TX, USA; University of Texas Southwestern Med Ctr, Dallas TX, USA
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Digestive and Liver Disease: Elsevier BV46:1, s. 36-401590-86581878-3562
Internetlänk
Hitta via bibliotek
Till lärosätets databas